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Are serum aluminum levels a risk factor in the appearance of
spontaneous pneumothorax?
Serdar HAN1, Rasih YAZKAN2, Bülent KOÇER3,*, Gültekin GÜLBAHAR3,
Serdal Kenan KÖSE4, Koray DURAL3, Ünal SAKINCI3

Aim: To investigate the relationship between aluminum and spontaneous pneumothorax (SP) development.
Materials and methods: A patient group and a control group were formed with 100 individuals in each. The serum
aluminum levels of the groups were determined and statistically compared.
Results: The mean serum aluminum levels were 5.6 ± 2.4 μg/L (1.6-11.9) and 23.2 ± 15.4 μg/L (2-81) in the control and
SP groups, respectively (P < 0.001). The specificity and sensitivity of the measurement of aluminum level were 74.4% and
86.4% in the SP group. The risk of SP development was found to be 18 times higher in individuals with high serum levels
of aluminum compared to that in individuals with low serum levels of aluminum.
Conclusion: A high level of aluminum is a risk factor for the development of SP.
Key words: Aluminum, pneumothorax, public health

Spontan pnömotoraks gelişiminde serum aluminyum
seviyeleri bir risk faktörü müdür?
Amaç: Bu çalışmada spontan pnömotoraks (SP) gelişimi ile serum aluminyum düzeyleri arasındaki ilişkinin analiz
edilmesi amaçlandı.
Yöntem ve gereç: Yüz SP hastasından oluşan hasta grubunun yanı sıra 100 kişiden oluşan sağlıklı kontrol grubu çalışmaya
dahil edildi. Gruplar serum aluminyum düzeyleri açısından istatistiksel olarak kıyaslandı.
Bulgular: Ortalama serum aluminyum düzeyleri SP ve kontrol grupları için sırasıyla 5,6 ± 2,4 μg/L (1,6-11,9) ve 23,2 ±
15,4 μg/L (2-81) bulundu (P < 0,001). SP grubunda serum aluminyum düzeyinin özgüllüğü % 74,4 iken duyarlılığı % 86,4
bulundu. Serum aluminyum düzeyi yüksek olan bireylerde, düşük tespit edilen bireylere kıyasla SP gelişme riski 18 kat
yüksek tespit edildi.
Sonuç: Yüksek serum aluminyum düzeyleri SP gelişiminde bir risk faktörü olabilir.
Anahtar sözcükler: Pnömotoraks, aluminyum, halk sağlığı

Introduction
Aluminum is the third most common element after oxygen and silica (1). It has recently been
shown to have adverse effects upon human health. Contact with aluminum cannot be avoided
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because it comprises about 8% of the earth's surface
(2).

thoracostomy, thoracotomy, and video assisted
thoracic surgery (VATS).

It was first reported in 1934 that the inhalation of
aluminum dusts caused pulmonary diseases. Fourteen
years later, 11 people with vocational pneumoinfections due to bauxite inhalation were reported (3).
It was also reported that Shaver’s disease involving
fibrosis with large bubbles and the symptoms of
potroom asthma had developed in workers employed
in the manufacture of aluminum (3). Aluminum is
known especially to play a role in Alzheimer’s disease
and also affects the other organ systems. However,
there has been no study concerning its causing of
bullae formation or spontaneous pneumothorax
evolution.

Thoracic CTs were performed after expansion of
the lung. The structure of the pulmonary parenchyma
was evaluated. Postoperative morbidity and mortality
were determined.

In our first study, the relationship between
aluminum and spontaneous pneumothorax (SP)
development was shown (4). The present study aimed
to show this relationship again with a large series and
to demonstrate serum aluminum level as a risk factor
in SP.

Statistical analysis
The statistical analyses of the data were performed
using SPSS for Windows 11.5. In the evaluation,
Student's t-test, Spearman rank correlation analysis,
chi-square test, and Fisher’s exact test were used. In
addition, receiver operating characteristic (ROC)
analysis was performed in order to determine the level
that best identified the aluminum levels in both the
control and patient groups, and this best level was
determined to be 6.95 μg/L (AUC: 0.904 ± 0.028, P <
0.001, Figure). Considering this value, odds ratio
(OR) was also calculated to determine the results of
the risk (5,6). Mean ± standard deviation values were
calculated as descriptive statistics. P < 0.05 was
considered significant.

Materials and methods

The treatment options for SP are conservative
management, needle aspiration, percutaneous
catheter for drainage (Heimlich valve, etc.), tube
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The patient group consisted of 100 patients who
presented to our clinic with the diagnosis of SP
between 2002 and 2008, and the control group
consisted of 100 healthy individuals who had no
complaints. Both groups underwent a physical
examination. The history of the subjects in both
groups was obtained, and all underwent routine blood
evaluations. X-rays and thoracic computed
tomography (CT) of all the subjects were also
performed. The serum aluminum levels of the
subjects were measured twice in the same laboratory.
The blood samples were taken after the patients had
been admitted to the clinic during the treatment.
Blood samples were taken into vacuumed tubes not
containing gel to avoid aluminum contamination and
were not opened before centrifugation. After
centrifugation serum materials were put into clean
tubes and stored at -80 °C. Atomic absorption
spectrometry (AAS) was used to determine the serum
aluminum levels.
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Figure. ROC analysis of sera aluminum levels.

Results
The mean age of the patients in the SP group was
32.25 ± 13.72 years (14-77 years). Ninety-five of the
patients (95%) in this group were male. The male
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predominance was statistically significant in the SP
group (P < 0.001). The mean age of the subjects in the
control group was 24.80 ± 7.59 years (17-47), and 60%
of the subjects in this group were male. The mean
level of aluminum in the blood samples of the SP
group was 23.2 ± 15.4 μg/L (2-81 μg/L) and the level
of aluminum in the control group was 5.6 ± 2.4 μg/L
(1.6-11.9 μg/L, Table 1).

The mean time since the onset of symptoms in the
patients with SP was 4.33 ± 17.02 days (1-150). It was
1 day in 67% of the patients. Recurrent SP developed
in 11 patients (11%), and we performed VATS in 6
patients (6%).
The serum levels of aluminum in the patients with
SP were higher (P < 0.001). According to ROC
analysis performed, the level that was able to best
identify the patient and control groups was 6.95 μg/L.
The risk of SP development in the patients with higher
than 6.95 μg/L serum aluminum level was 18 times
that of the controls (OR=18.46, 95% CI: 7.07-48.18).
In the patient group, there was not a significant
difference between the amount of aluminum in males
and females. Seventy-eight of the patients were
smokers (78%). Serum aluminum level in SP patients
who were smokers was 25 μg/L while the level was
16.9 μg/L in the non-smokers; the difference between
them was statistically significant (P < 0.01, Table 2).
Twenty-four of the controls were smokers (24%).
Serum aluminum level in the controls who were

SP was on the right in 64 patients (64%), and the
mean aluminum level on the right was 25.8 μg/L and
the mean aluminum level on the left was 18.6 μg/L in
the patients with SP. The difference between the 2
values was statistically significant (P < 0.05, Table 2).
Seventy-one (71%) of the SP patients had bullous
lesions on the thoracic CTs and the mean aluminum
level of these patients was 25.8 μg/L, while it was 16.7
μg/L in the patients with no bullous lesions. The
difference was statistically significant (P < 0.05, Table
2), and none of the subjects in the control group had
bullous lesions, and all the other results of the control
group were normal.

Table 1. The results of 3 studies on patients with spontaneous pneumothorax and healthy controls.
Serum Aluminum Levels (μg/L)
Study
Han (2004)
Leo (2005)
Han (2008)

N

SP Mean ± SD

Control Mean ± SD

P

60
20
200

18.4 ± 14.6
3.8 ± 1.2
23.2 ± 15.4

2.7 ± 0.8
4.6 ± 1.8
5.6 ± 2.4

<0.001
0.19
<0.001

Table 2. Relationship between side of pneumothorax, bullous lesions on computed thorax tomography,
smoking, and aluminum level in the patient group.
Serum Aluminum Levels (μg/L)
N

Mean ± SD

Right

64

25.8 ± 16.9

Left

36

18.6 ± 11.2

Bullae (+)

71

25.8 ± 16.2

Bullae (–)

29

16.7 ± 11.1

(+)

78

25.0 ± 16.7

(–)

22

16.9 ± 7.3

Side

P

<0.05

Lesions

<0.05

Smoking

<0.01
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smokers was 6.1 ± 2.9 μg/L, while it was 5.4 ± 2.2 μg/L
in the non-smokers. There was no statistically
significant difference between the smokers and
nonsmokers in the control group (P > 0.05).
The mean serum aluminum levels were 24.9 μg/L
and 19.5 μg/L in the patients whose period of
symptoms was 1 day and longer than 1 day,
respectively (P > 0.05). The mean serum aluminum
levels were 24.0 μg/L and 16.6 μg/L in the patients
with relapse and those with no relapse, and 23.4 μg/L
and 20.7 μg/L in the operated and not operated
patient groups for SP, respectively (P > 0.05, P > 0.05,
respectively).
No postoperative complications or mortality
occurred.
Discussion
It was first reported in 1934 that the inhalation of
aluminum dusts caused pulmonary diseases. Fourteen
years later, as a result of bauxite inhalation, 11 people
with vocational pneumo-infections (Shaver disease)
were reported (3,7). Pulmonary fibrosis and
emphysema are known to have occurred in workers
who were exposed to aluminum oxide and silica
smog. In addition, it was reported that some
granulomatous lesions developed in the respiratory
bronchi in laboratory animals exposed to high
concentrations of aluminum chlorohydrate used as
aerosol antiperspirant (8). The clinical picture occurs
in the form of dyspnea, cough, and pneumothorax,
and nodular interstitial fibrosis develops as a
histopathologic sign. In workers exposed to pure
aluminum dusts, it has been reported that pulmonary
fibrosis develops, which has been termed aluminosis
(9,10). Aluminum may also cause Shaver’s disease,
which causes fibrosis and respiratory problems with
large bullae, and SP is a frequently occurring
complication (11). In workers employed in the
manufacture of aluminum, potroom asthma
symptoms were reported, but the exact etiology is not
clear. In a 32-year-old worker employed for 8 years in
an atmosphere containing aluminum dusts,
development
of
sarcoid-like
pulmonary
granulamatosis was reported (12).
Because of its physical and chemical properties,
aluminum has a very wide area of usage, including the
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drug and cosmetic industries. The contact with
aluminum occurs mainly with food and kitchen
utensils and through many ways such as dietary,
environmental, and therapeutic procedures (13). It is
reported that the highest level of aluminum is found
in the lungs, and it is 20 mg/kg in terms of age and
weight. This has been attributed to the accumulation
of insoluble compounds entering the lungs through
respiration. Pulmonary aluminum concentration
increases with age, depending on the continuation of
the environmental contact and physiological changes
(14,15).
Smoking is another factor that increases the body’s
burden of aluminum (16). In our study, the serum
aluminum levels of the smokers were higher than
those of the non-smokers; 78 of the patients (78%)
were smokers, and the level of aluminum in the blood
plasma of the SP patients who smoked was 24.98 μg/L,
while it was 16.94 μg/L in the non-smokers. The
difference between the aluminum levels of these
patients was statistically significant. None of our
patients had chronic obstructive pulmonary disease
or bronchial asthma according to lung function test
results, all of which were normal.
None of our patients in the study group had any
vocational history related to aluminum, and most of
them lived in urban areas. Nevertheless, aluminum
has such wide usage that it is impossible to avoid
contact with it. It is clear that aluminum has a
pathologic effect on the lungs and other systems, as
shown in previous studies. In our study, the
aluminum levels of the SP patients were significantly
higher than those of the controls.
This study comprises our second report on this
issue. Higher plasma concentrations of aluminum in
patients with SP were reported (4); however, another
study, from France, did not confirm the relationship
between aluminum and SP (17).
Conclusion
Aluminum may play a role in SP etiology, causing
the development of subpleural bleb and bullous
lesions. It is obvious that it will give us a clear idea in
the prognosis and treatment of SP and it can be
supposed that a high level of aluminum in blood
plasma is a risk factor for SP development.
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Environmental agents or differences in the
characteristics of different regions may have played
an important role in establishing this relationship, but
the findings of our study may be helpful for thoracic

surgeons in the treatment and follow up of SP and can
be used for occupational decision-making and public
health management.
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